Sign In
Buy HSKA
$119.99
+0 (+0%)
At Close: Sep 11, 2023
5 Toxic Stocks That May Prove Hazardous for Your Portfolio
09:02am, Monday, 08'th Aug 2022
Toxic companies are characterized by huge debt pile and are vulnerable to external shocks. Accurately identifying such stocks and getting rid of them at the right time can protect your portfolio.
Analyst Ratings for Heska
01:16pm, Tuesday, 10'th May 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Heska (NASDAQ:HSKA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's
Heska Corp (HSKA) CEO Kevin Wilson on Q1 2022 Results - Earnings Call Transcript
01:56pm, Monday, 09'th May 2022
Heska Corp (NASDAQ:HSKA ) Q1 2022 Earnings Conference Call May 9, 2022 11:00 AM ET Company Participants Jon Aagaard - Director, IR Kevin Wilson - CEO, President & Director Catherine Grassman - EVP & C
Heska (HSKA) Misses Q1 Earnings and Revenue Estimates
01:35pm, Monday, 09'th May 2022 Zacks Investment Research
Heska (HSKA) delivered earnings and revenue surprises of -34.15% and 3.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Heska (HSKA) Misses Q1 Earnings and Revenue Estimates
11:18am, Monday, 09'th May 2022
Heska (HSKA) delivered earnings and revenue surprises of -34.15% and 3.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Tops Revenue Estimates
01:25pm, Thursday, 05'th May 2022 Zacks Investment Research
Mirum Pharmaceuticals, Inc. (MIRM) delivered earnings and revenue surprises of 15.83% and 48.59%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the s
Regeneron (REGN) Q1 Earnings and Revenues Beat Estimates
11:45am, Wednesday, 04'th May 2022 Zacks Investment Research
Regeneron (REGN) delivered earnings and revenue surprises of 22.63% and 9.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Heska (HSKA) Q1 Earnings Expected to Decline
07:00pm, Monday, 02'nd May 2022 Zacks Investment Research
Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VolitionRx strikes exclusive $28M deal with Heska Corp to sell its Nu.Q vet cancer screening test
10:34am, Tuesday, 29'th Mar 2022
VolitionRx (NYSE-A:VNRX) Ltd has struck an exclusive $28 million deal with veterinary diagnostic firm Heska Corporation to license and sell the former's Nu.Q vet cancer screening test at the point-of
Heska Corporation''s (HSKA) CEO Kevin Wilson on Q4 2021 Results - Earnings Call Transcript
07:27pm, Monday, 28'th Feb 2022 Seeking AlphaHeska Corporation's (HSKA) CEO Kevin Wilson on Q4 2021 Results - Earnings Call Transcript
02:27pm, Monday, 28'th Feb 2022
Heska Corporation's (HSKA) CEO Kevin Wilson on Q4 2021 Results - Earnings Call Transcript
Heska (HSKA) Tops Q4 Earnings and Revenue Estimates
02:25pm, Monday, 28'th Feb 2022 Zacks Investment Research
Heska (HSKA) delivered earnings and revenue surprises of 9.38% and 3.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Heska Non-GAAP EPS of $0.35 beats by $0.03, revenue of $68.06M beats by $2.03M
01:07pm, Monday, 28'th Feb 2022 Seeking Alpha
Heska press release (HSKA): Q4 Non-GAAP EPS of $0.35 beats by $0.03.Revenue of $68.06M (+5.8% Y/Y) beats by $2.03M.2022 Outlook: Revenue expected to be in the range of $287M -$297M…
Heska Corporation Reports Fourth Quarter and Full Year 2021 Results
01:00pm, Monday, 28'th Feb 2022 PR Newswire
LOVELAND, Colo., Feb. 28, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its fourth quarter…
Heska (HSKA) Tops Q4 Earnings and Revenue Estimates
10:45am, Monday, 28'th Feb 2022
Heska (HSKA) delivered earnings and revenue surprises of 9.38% and 3.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
